02.02.2016 18:05:54

Press Release: Invitation: Actelion to discuss full year 2015 financial results

Actelion Pharmaceuticals Ltd / Invitation: Actelion to discuss full year 2015 financial results . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community

Actelion Ltd will announce its 2015 full year financial results on Tuesday, 9 February 2016, at 07.00 hrs CET / 06.00 hrs GMT / 01.00 a.m. EST.

An investor conference call & webcast will be held at 14.00 hrs, CET to discuss the results.

To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate

Date/Time:

9 February 2016 14.00 hrs - 14.45 hrs Basel (CET) 13.00 hrs - 13.45 hrs UK (GMT) 8.00 a.m. - 8.45 a.m. US (EST)

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial: Europe: +41 (0)44 583 18 01 UK: +44 (0)203 194 05 61 US: +1 646 722 48 98

Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.

Participants will be asked for their Name and Company.

Webcast Access:

Webcast participants should visit the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.

Participant's mode: Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com/ approximately 60 minutes after the call has ended.

Invitation PDF: http://hugin.info/131801/R/1983095/726688.pdf

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via Globenewswire

HUG#1983095

--- End of Message ---

Actelion Pharmaceuticals Ltd

Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;

http://www.actelion.com (END) Dow Jones Newswires

   February 02, 2016 11:35 ET (16:35 GMT)- - 11 35 AM EST 02-02-16

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Actelion Ltd.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Actelion Ltd.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 524,01 -2,20%